Meg discusses how COVID-19 was a transformational moment for the pharmaceutical industry, and how it has forced companies to re-examine, at multiple levels, the way they do business. Meg and Bozidar delve into innovation in the biotech industry, and how businesses will find new methods to connect and rely on solid partnerships by developing meaningful relationships that provide mutual value and advantages. Meg also talks about how innovation has influenced the activities of Medical Affairs and MSLs, and the evolving role of Medical Affairs in pharma launches.